'We Are Not Guinea Pigs': The Effects of Negative News on Vaccine Compliance

Archibong, Belinda; Annan, Francis

doi:10.2139/ssrn.3765793

Cited by 9 publications

(9 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Secondly, we contribute to the sparse literature that generates causal evidence about what underpins the acceptance of vaccines in LICs and LMICs, being among one of the first experiments to explicitly focus on COVID-19 vaccines. Seminal studies prior to the COVID-19 pandemic have tended to focus on how mistrust towards vaccines was influenced by questionable activities being brought to light (Archibong and Annan, 2021;Martinez-Bravo and Stegmann, 2022). Since the outset of the pandemic there has been some experimental work in high-income countries about ways to boost COVID-19 vaccine acceptance (e.g., Kaplan and Milstein, 2021), but in LICs and LMICs existing publicly available studies have been almost exclusively descriptive (e.g., Kanyanda et al, 2021).…”

Section: Introductionmentioning

confidence: 99%

Intra-Household Dynamics and Attitudes toward Vaccines: Experimental and Survey Evidence from Zambia

Hoy¹,

Kanagavel²,

Cameron³

2022

Policy Research Working Papers

View full text Add to dashboard Cite

The Policy Research Working Paper Series disseminates the findings of work in progress to encourage the exchange of ideas about development issues. An objective of the series is to get the findings out quickly, even if the presentations are less than fully polished. The papers carry the names of the authors and should be cited accordingly. The findings, interpretations, and conclusions expressed in this paper are entirely those of the authors. They do not necessarily represent the views of the International Bank for Reconstruction and Development/World Bank and its affiliated organizations, or those of the Executive Directors of the World Bank or the governments they represent.

show abstract

Section: Introductionmentioning

confidence: 99%

Intra-Household Dynamics and Attitudes toward Vaccines: Experimental and Survey Evidence from Zambia

Hoy¹,

Kanagavel²,

Cameron³

2022

Policy Research Working Papers

View full text Add to dashboard Cite

show abstract

“…There is anecdotal evidence and media reports of distrust of pharmaceutical companies in LMICs, including concerns that people in such countries could be used as "guinea pigs" to pilot-test vaccines not yet approved for use elsewhere in high-income countries. [84][85][86][87] For example, in Nigeria, there are reported cases of child and infant deaths and disabilities following the administration of an experimental drug during a meningitis outbreak. 88 Such events create unprecedented adverse experiences that could hinder vaccine uptake and the understanding of clinical research to test new vaccines.…”

Section: Distrust In Pharmaceutical Companiesmentioning

confidence: 99%

Respiratory syncytial virus immunoprophylaxis: Novel opportunities and a call for equity

Rzymski,

Gwenzi

2024

Journal of Medical Virology

View full text Add to dashboard Cite

With the approval of the first vaccines against respiratory syncytial virus (RSV) and a novel RSV‐neutralizing antibody, 2023 has been perceived as a game‐changing year in preventing severe outcomes of RSV infections in infants and the elderly. However, the costs of these pharmaceuticals are high, while RSV disproportionately impacts populations of low‐to‐middle‐income regions, which may continue to suffer from a lack of pharmaceutical measures for RSV prevention under health and socioeconomic disparities. This paper presents an overview of the characteristics, clinical results, and approval status of various RSV vaccines and anti‐RSV antibodies. It posits that wealthy nations cannot monopolize RSV immunoprophylaxis and should work jointly to make it available to lower‐income countries. An approach toward RSV immunoprophylaxis equity based on five points is offered: (1) integration of RSV vaccines and antibodies into the existing global humanitarian distribution systems, (2) using affordable RSV vaccine pricing models, (3) enforcing equity as a part of national and global public health strategy, (4) implementing equitable allocation frameworks for RSV immunoprophylaxis, and (5) promoting local manufacturing. Such a plan needs to be put into action as soon as possible to avoid delays in serving the populations with the highest needs related to RSV burden.

show abstract

“…For another thing, vaccine compliance is strongly influenced by the environment, that is, where and when this individual decision is taken. For example, Archibong and Annan (2021), A. Banerjee et al (2021), Hansen and Schmidtblaicher (2021), Lowes and Montero (2021), and Martinez‐Bravo and Stegmann (2021) document that propaganda, the authority's miscommunication, medical malpractice, or the campaign design have strong effects on vaccine compliance. Simply regressing economic insecurity on the individual decision of getting the COVID‐19 vaccine will therefore lead to a biased estimation due to an underlying endogeneity problem.…”

Section: Empirical Strategymentioning

confidence: 99%

Safe at Last? Late Effects of a Mass Immunization Campaign on Households' Economic Insecurity

Belmonte

Pickard

2023

Review of Income and Wealth

View full text Add to dashboard Cite

We study the effects of receiving immunization from COVID‐19 on households' economic insecurity. To provide causal estimates we use a fuzzy regression discontinuity design which takes advantage of the UK's immunization plan. The plan was primarily based on age, granting differential eligibility to proximate cohorts. Our estimated local average treatment effect indicates that the share of households who declared being economically insecure dropped by 41 percentage points among those who received the vaccine due to the eligibility criteria. Using a difference‐in‐discontinuity design we next document that immunization was more salient for women as well as for large households and those with children. Our results suggest that the mass immunization campaign against COVID‐19 had relevant short‐run economic effects, well beyond its expected impact on people's health.

show abstract

'We Are Not Guinea Pigs': The Effects of Negative News on Vaccine Compliance

Cited by 9 publications

References 27 publications

Intra-Household Dynamics and Attitudes toward Vaccines: Experimental and Survey Evidence from Zambia

Intra-Household Dynamics and Attitudes toward Vaccines: Experimental and Survey Evidence from Zambia

Respiratory syncytial virus immunoprophylaxis: Novel opportunities and a call for equity

Safe at Last? Late Effects of a Mass Immunization Campaign on Households' Economic Insecurity

Contact Info

Product

Resources

About